Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB1 | P46663 | 12/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 6/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12012120 | 0.95 | BDKRB1 (0.39) | BDKRB1F10 | |
| SCHEMBL13063111 | 0.94 | BDKRB1 (0.38) | BDKRB1 | |
| SCHEMBL13063132 | 0.88 | F10 (0.36) | F10 | |
| SCHEMBL13063102 | 0.87 | BDKRB1 (0.38) | BDKRB1F10 | |
| SCHEMBL3440165 | 0.85 | BDKRB1 (0.56) | BDKRB1 | |
| SCHEMBL13876908 | 0.81 | BDKRB1 (0.46) | BDKRB1 | |
| SCHEMBL3439848 | 0.80 | BDKRB1 (0.40) | BDKRB1F10 | |
| SCHEMBL3440246 | 0.80 | BDKRB1 (0.57) | BDKRB1 | |
| SCHEMBL10118663 | 0.79 | BDKRB1 (0.37) | BDKRB1ALDH1A1F10 | |
| SCHEMBL13063150 | 0.79 | BDKRB1 (0.49) | BDKRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110294775-A1 | NOVEL COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294775-A1 | NOVEL COMPOUNDS | TRPV1, OPRL1, TRPA1 | BDKRB1 80/4885ALDH1A1 2740/4885MAPT 2138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.